Callan Family Office’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Sell
11,581
-4,343
-27% -$86.2K ﹤0.01% 1096
2026
Q1
$306K Buy
15,924
+492
+3% +$9.69K 0.01% 924
2025
Q4
$292K Buy
+15,432
New +$286K 0.01% 936

Other funds holding SBRA

Callan Family Office's SBRA Position: Q2 2026 in Review

Callan Family Office reduced its Sabra Healthcare REIT (SBRA) stake by 27% in Q2 2026, selling an estimated $86.2K and leaving 11,581 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #1096.

Callan Family Office first reported a position in SBRA in Q4 2025 and has held it in 3 quarters since. The position peaked at $306K in Q1 2026. 466 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Callan Family Office held 11,581 shares of Sabra Healthcare REIT worth $226K as of Q2 2026.
  • Callan Family Office sold 4,343 Sabra Healthcare REIT shares in Q2 2026, an estimated $86.2K.
  • Sabra Healthcare REIT made up ﹤0.01% of Callan Family Office's portfolio in Q2 2026, its #1096 holding.
  • Callan Family Office first reported a position in Sabra Healthcare REIT in Q4 2025 and has held it in 3 quarters since.
  • Callan Family Office's Sabra Healthcare REIT position peaked at $306K in Q1 2026.
  • 466 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.